Article Versions Notes

Bukaeva AA, Blokhina AV, Kharlap MS, Zaicenoka M, Zotova ED, Petukhova AV, Garbuzova EV, Zharikova AA, Divashuk MG, Kiseleva AV, et al. A Novel Bradycardia-Associated Variant in HCN4 as a Candidate Modifier in Type 3 Long QT Syndrome: Case Report and Deep In Silico Analysis. Biomedicines. 2025; 13(4):1008. https://doi.org/10.3390/biomedicines13041008

Bukaeva, Anna A., Anastasia V. Blokhina, Maria S. Kharlap, Marija Zaicenoka, Evgenia D. Zotova, Anna V. Petukhova, Elizaveta V. Garbuzova, Anastasia A. Zharikova, Mikhail G. Divashuk, Anna V. Kiseleva, and et al. 2025. "A Novel Bradycardia-Associated Variant in HCN4 as a Candidate Modifier in Type 3 Long QT Syndrome: Case Report and Deep In Silico Analysis" Biomedicines 13, no. 4: 1008. https://doi.org/10.3390/biomedicines13041008

Bukaeva, A. A., Blokhina, A. V., Kharlap, M. S., Zaicenoka, M., Zotova, E. D., Petukhova, A. V., Garbuzova, E. V., Zharikova, A. A., Divashuk, M. G., Kiseleva, A. V., Ershova, A. I., Meshkov, A. N., & Drapkina, O. M. (2025). A Novel Bradycardia-Associated Variant in HCN4 as a Candidate Modifier in Type 3 Long QT Syndrome: Case Report and Deep In Silico Analysis. Biomedicines, 13(4), 1008. https://doi.org/10.3390/biomedicines13041008